Spiro- and substituted tetrahydrobenzo[b]thiophene-triazaphospholes and phosphoramidates as potent antineoplastic agents: synthesis, biological evaluation, and SAR studies
作者:Wafaa M. Abdou、Neven A. Ganoub、Eman Sabry
DOI:10.1007/s00706-015-1542-4
日期:2016.3
reaction of trimethyl, triethyl, and triisopropylphosphites with 2-azido-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile was developed and furnished spiro-triazaphosphole-oxide derivatives in ≈70 % yield. Contrary to these results, linear substituted phosphoramidates were obtained from the reaction of the azide with dimethyl, diethyl, and diisopropyl phosphites. N-Alkylamino- or 2-aminotetrahydr
摘要开发了亚磷酸三甲酯,亚磷酸三乙酯和亚磷酸三异丙酯与2-叠氮基-4,5,6,7-四氢苯并[ b ]噻吩-3-甲腈的新型高效共轭加成反应,并提供了约70%的螺-三氮杂膦氧化物衍生物让。与这些结果相反,从叠氮化物与亚甲基二甲基,二乙基和二异丙基亚磷酸酯的反应获得线性取代的氨基磷酸酯。N-烷基氨基-或2-氨基四氢苯并[ b还从前两个反应中以约10%的收率分离出了] thiophene-3-carbitrile。在这项工作的背景下,仅在质子化剂(乙醇)的存在下,才使六烷基磷三酰胺与相同的底物反应,得到相应的磷酸三酰胺。这三个反应平稳,干净地进行,并在室温下约6小时内完成。根据结构-活性关系,讨论了该产品的抗乳腺癌,抗结肠和抗前列腺癌细胞系药理评价结果,以定义铅化合物的发色团。 。 图形概要
Compositions useful as inhibitors of voltage-gated sodium channels
申请人:Gonzalez E. Jesus
公开号:US20060025415A1
公开(公告)日:2006-02-02
The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
申请人:Gonzalez, III Jesus E.
公开号:US20100087479A1
公开(公告)日:2010-04-08
The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS
申请人:Gonzalez, III Jesus E.
公开号:US20120238578A1
公开(公告)日:2012-09-20
The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.